The Department of Justice (“DOJ” or the “Government”) and Bartell Drug, Inc. (“Bartell”), a Washington State pharmacy chain of approximately 70 pharmacies, recently reached a civil settlement in which Bartell agreed to pay a fine... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Criminal Defense & Government Investigations

As the opioid crisis continues to result in devastating consequences throughout the country, the U.S. Department of Justice (the “DOJ”) is broadening its opioid enforcement to all stakeholders involved in the opioid supply chain including,... Read More
Blogs & Articles | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

Frier Levitt has identified an alarming trend in government investigations of pharmacies whereby Office of Inspector General (“OIG”) and Drug Enforcement Administration (“DEA”) issue subpoenas simultaneously or almost at the same time. ... Read More
Blogs & Articles | Community, Retail Pharmacies | Life Sciences | Regulatory Compliance, including FDA, DEA and HIPAA

Inspections are not uncommon in the world of healthcare and life sciences. State licensing boards, DEA, and other oversight agencies at times assert a right to inspect a medical practice or pharmacy. They usually show up unscheduled and at an... Read More
Blogs & Articles | Healthcare Law | Pharmacy Law | White Collar Criminal Defense & Government Investigations | White Collar Criminal Defense & Government Investigations

If your pharmacy has been vandalized or looted in the recent riots that have affected many cities and towns across the country, depending on the issue, there may be a number of notifications that the pharmacy is required to make as it relates to the... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | Industry | Life Sciences | Pharmacy Law | Specialty Pharmacies

In an effort to facilitate continuity of patient care and to respond appropriately to the circumstances that have arisen during the COVID-19 pandemic, the Drug Enforcement Administration (“DEA”) has recently announced three exceptions to DEA... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | COVID-19 Resources | Life Sciences | Pharmacy Law | Physician Dispensing | Regulatory Compliance, including FDA, DEA and HIPAA | Specialty Pharmacies